iShares iBonds Dec 2027 Term Treasury ETF (NASDAQ: IBTH)

iShares iBonds Dec 2027 Term Treasury ETF (NASDAQ:IBTH), Quote.Headers.trade-ideas

The Fund seeks to meet its investment objective generally by investing in individual securities which satisfy the criteria of the ICE 2027 Maturity US Treasury Index (the Underlying Index). The Fund may also invest in short-term paper, cash and cash equivalents, including shares of money market funds advised by BFA or its affiliates.

iShares iBonds Dec 2027 Term Treasury ETF

<a href="https://www.defense.gov/News/Contracts/Contract/Article/3910169/" title="https://www.defense.gov/News/Contracts/Contract/Article/3910169/">https://www.defense.gov/News/Contracts/Contract/Article/3910169/</a>

News

Contracts

GNTX

Reported September 18; Gentex Awarded $8.1M Contract Modification For HGU-56/P Aircrew Helmet System And Components, With Completion Expected By September 2025

Reported September 18; Teledyne FLIR Awarded $13.2M Contract Modification For IdentiFINDER Systems And Support, With Work To Be Completed By September 2027

FibroBiologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBLG#NASDAQ">FBLG</a>) ("FibroBiologics"), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it has engaged with Southern Star Research to provide clinical research organization (CRO) services for FibroBiologics in Australia. Initial CRO services will include preparatory work for a Phase 1/2 clinical trial utilizing product candidate, CYWC628, to treat diabetic foot ulcers.

Biotech

Global

General

FBLG

FibroBiologics Engages Southern Star Research As Clinical Research Organization In Australia, Initial CRO Services Will Include Preparatory Work For A Phase 1/2 Clinical Trial Utilizing Product Candidate, CYWC628, To Treat Diabetic Foot Ulcers

Reported September 18; Northrop Grumman Awarded $17.9M Contract For Inertial Measuring Units For WSN-7 Weapon System, Work To Be Completed By June 2030

Reported September 18; Boeing Awarded $29.5M Contract For F/A-18 E/F Black III Windshield Panel Spares, Work To Be Completed By December 2029

Reported September 18; Raytheon Awarded $18.6M Contract For International Field Artillery Tactical Data Systems, With Completion Expected By September 2026, Funded By 2024 Foreign Military Sales To Georgia

PLTR

Reported September 18; Palantir USG Awarded $99.8M Contract For Maven Smart System AI Tool, Software Support, And Hardware, With Completion Expected By September 2029

T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) shares are trading higher today. The company disclosed long-term <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925481/fueled-by-network-leadership-and-transformative-ai-enabled-customer-experiences-t-mobile-outlines-" rel="noreferrer noopener">goals, AI deals, and a dividend hike on Wednesday.</a>
T-Mobile revealed a three-year plan to drive growth. The strategy comprises expanding its AI-driven, digital-first approach, increasing market share in underpenetrated areas, boosting broadband growth, and exploring new revenue streams.
The company exceeded its 2021 Capital Markets Day goals, including building a solid network in America, expanding market reach, and achieving $8 billion in synergies from the Sprint merger.
Apart from this, T-Mobile plans to enhance its network leadership with advanced technologies like Massive MIMO, VoNR, and 5G Advanced, backed by its nationwide 5G standalone network.
In a separate release, T-Mobile and OpenAI disclosed a transformative multi-year partnership aimed at revolutionizing customer experience. This collaboration merges T-Mobile&#8217;s deep customer relationship skills with OpenAI&#8217;s cutting-edge <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40922898/t-mobile-and-openai-join-forces-to-revolutionize-the-customer-experience-with-first-ever-intent-dr" rel="noreferrer noopener">AI technology and R&amp;D capabilities</a>.
T-Mobile CEO Mike Sievert said, &#8220;T-Mobile is a company on the move with tremendous opportunities in front of us to further extend our outperformance in customer growth and translate that into strong top and bottom-line growth that will enable a compelling capital return opportunity over the next few years,&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40925493/t-mobile-partners-with-nvidia-ericsson-and-nokia-to-pioneer-ai-driven-mobile-networks" rel="noreferrer noopener">T-Mobile Partners with NVIDIA, Ericsson, And Nokia to Pioneer AI-Driven Mobile Networks</a>
Outlook: T-Mobile expects service revenue between $75 billion and $76 billion and adjusted free cash flow of<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> $18 billion-$19 billion in 2027</a>.
T-Mobile for Business (TFB) is anticipated to deliver double-digit growth, with overall service revenue projected to grow at a 5% CAGR from 2023 to 2027.
The company now targets 12 million 5G broadband customers by 2028, significantly raising its previous goal of 7 to 8 million by 2025.
The company projects core Adjusted EBITDA growth, targeting $38 billion&nbsp;to $39 billion in 2027, reflecting a 7% CAGR at the midpoint from 2023 and a $10 billion increase from 2023 at the high end of&nbsp;guidance.
This growth is expected to be fueled by operational leverage and efficiencies from technology, AI, and digital innovation.
Dividend Boost: T-Mobile disclosed that its Board of Directors has declared a cash dividend of $0.88 per share, reflecting a 35% increase from the previous quarter.
The dividend will be payable on December 12, 2024, to stockholders of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925518/t-mobile-announces-a-35-quarterly-dividend-increase" rel="noreferrer noopener">record as of November 27, 2024</a>.
Also, the company plans to allocate around $80 billion through 2027 for investments and shareholder returns, including up to $50 billion for dividends and share repurchases (in addition to the $25 billion already returned to shareholders).
Apart from this, T-Mobile introduced T-Priority, the world&#8217;s first 5G network slice dedicated to first responders, providing advanced connectivity solutions and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40925495/t-mobile-introduces-t-priority-featuring-the-worlds-first-network-slice-for-first-responders" rel="noreferrer noopener">unparalleled support for emergency situations</a>.
Investors can focus on the stock via&nbsp;The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)and&nbsp;Invesco BuyBack Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKW#NASDAQ">PKW</a>).
Price Action: TMUS shares are up 1.04% at $198.73 at the last check Thursday.
Photo by viewimage on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40932937/apple-iphone-16-selling-at-a-greater-rate-than-last-year-says-t-mobile-ceo-amid-reports-of-lower" target="_blank" rel="noreferrer noopener">Apple iPhone 16 Selling At A &#8216;Greater Rate Than Last Year,&#8217; Says T-Mobile CEO Amid Reports Of Lower Demand: &#8216;People Are Buying Pros, They&#8217;re Buying Maxs… They&#8217;re Buying Up The Food Chain&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Large Cap

Guidance

TMUS

T-Mobile Surpasses 2021 Capital Markets Day Goals, Sets New Ambitions, Boosts Dividend & More

Clinical Advisory Board to Provide Strategy for Advancing Preclinical Oncology Program in Mesothelioma
AUSTIN, Texas, Sept. 19, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4258494-1&amp;h=4023088732&amp;u=https%3A%2F%2Fwww.genprex.com%2F&amp;a=Genprex%2C+Inc.">Genprex, Inc.</a> ("Genprex" or the "Company") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the formation of a Mesothelioma Clinical Advisory Board to support the Company's preclinical mesothelioma oncology program. The Board is comprised of four world-renown researchers from major research institutions specializing in the treatment of mesothelioma.

Penny Stocks

GNPX

Genprex Announces Formation Of Mesothelioma Clinical Advisory Board  To Provide Strategy For Advancing Preclinical Oncology Program In Mesothelioma

Wells Fargo analyst James Feldman upgrades Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) from Equal-Weight to Overweight and raises the price target from $70.5 to $82.

Upgrades

Price Target

Analyst Ratings

Wells Fargo Upgrades Equity Lifestyle Props to Overweight, Raises Price Target to $82

Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares are trading lower Thursday as lockup restrictions that have prevented certain insiders from selling shares <a href="https://www.benzinga.com/news/24/09/40869694/trump-media-faces-4b-downslide-as-shareholders-prepare-for-lockup-agreement-expiration">are set to expire</a>.
What To Know: Trump Media, the parent company of social media platform Truth Social,&nbsp;has been popular among retail investors since special purpose acquisition company Digital World first announced intentions to merge with the company. Trump Media made its public debut in late March. The stock traded as high as $79 before pulling back and trending lower.
Former President Donald Trump, who is the majority shareholder of Trump Media, as well as several other insiders, were restricted from selling any shares for approximately 180 days due to the lockup agreement. The lockup period expires Thursday, per <a href="https://www.cnbc.com/2024/09/18/djt-trump-media-slips-merger-lockup.html">CNBC</a>.
Trump Media shares have been very volatile since the start of the year. Just last week, the stock <a href="https://www.benzinga.com/general/social-media/24/09/40860859/trump-media-technology-shares-surge-former-president-says-hes-not-selling-or-leaving-truth-s">jumped as much as 25%</a> after Trump said he had &#8220;absolutely no intention of selling&#8221; any of his stake in the company. Trump reportedly owns close to a 57% stake in Trump Media. As of Wednesday&#8217;s close, the Republican presidential nominee&#8217;s&nbsp;stake was worth approximately $1.8 billion.
Trump Media shares fell 3.22% on Wednesday, a day ahead of the expiration. On Tuesday, shares slid more than 6% after a Delaware judge ruled that Trump Media breached a contract with ARC Global,&nbsp;ruling that the company must grant the early investor a larger portion of its stock than it planned to.
ARC Global reportedly holds a 4.77% stake in Trump Media. Those shares are likely going to be freed up for a potential sale once the lockup period expires on Thursday.
See Also: <a href="https://www.benzinga.com/news/24/09/40931458/obama-era-economist-says-she-is-pleasantly-surprised-that-jd-vance-thinks-the-economy-is-too-strong">Obama-Era Economist Says She Is &#8216;Pleasantly Surprised&#8217; That JD Vance Thinks The &#8216;Economy Is Too Strong For The Rate Cut&#8217;</a>
DJT Price Action: <a href="http://benzinga.com/quote/djt">Trump Media shares</a> were down 3.81% at $15.03 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

Trump Media & Technology Group Stock Slides As Lockup Expiration Looms: What's Going On?

Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the pricing of its underwritten follow-on public offering (the "Offering") of 4,000,000 units (each a "Unit," and collectively, the "Units") at an offering price of $3.00 per Unit (the "Public Offering Price") for total gross proceeds of $12,000,000, before deducting underwriting discounts and other offering expenses. Each Unit consists of (i) one share of Class A Ordinary Share, par value $0.0001 per share (the "Class A Ordinary Share") (or one pre-funded warrant to purchase one Class A Ordinary Share (the "Pre-Funded Warrant")), (ii) one Series A warrant to purchase one Class A Ordinary Share (the "Series A Warrant") (subject to certain adjustments therein), and (iii) one Series B warrant to purchase such number of Class A Ordinary Share described in the prospectus of the Offering (the "Series B Warrant", together with the Series A Warrant, the "Warrants"). The Warrants will have a term of 5 years from the closing date of the Offering (the "Closing Date"). The Series A Warrant is exercisable immediately upon issuance, or the Closing Date. The Series B Warrant is exercisable at any time on or after the sixteenth (16th) calendar day from the Closing Date (the "Series B Exercise Date"). The Series A Warrants have an initial exercise price of $3.00 per Class A Ordinary Share. On the Series B Exercise Date, the exercise price of the Series A Warrant will be adjusted to $0.60 and the maximum number of Class A Ordinary Shares issuable upon exercise of the Series A Warrants will be adjusted to 20,000,000 shares. The exercise price of the Series B Warrants is $0.0001 per Class A Ordinary Share. The maximum number of shares issuable upon exercise of the Series B Warrants will be 16,000,000 shares. The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The Class A Ordinary Shares, the Pre-Funded Warrants, and related Warrants are immediately separable and will be issued separately in the Offering.

Offerings

Haoxi Health Technology Limited Announces Pricing Of A $12M Underwritten Follow-On Public Offering Of 4M Units At A Price Of $3/Unit

WIIM

AIM ImmunoTech shares are trading higher after the company announced preliminary data from its Phase 1b/2 study of Ampligen and Imfinzi.

Fortinet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NYSE">FTNT</a>) short percent of float has risen 5.34% since its last report. The company recently reported that it has 13.72 million shares sold short, which is 2.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Fortinet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726752632_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Fortinet has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Fortinet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Fortinet's peer group average for short interest as a percentage of float is 4.64%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

FTNT

Peering Into Fortinet's Recent Short Interest

Boot Barn Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) short percent of float has fallen 4.06% since its last report. The company recently reported that it has 2.98 million shares sold short, which is 11.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Boot Barn Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726752620_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boot Barn Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Boot Barn Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Boot Barn Holdings's peer group average for short interest as a percentage of float is 17.15%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BOOT

Peering Into Boot Barn Holdings's Recent Short Interest

RBC Capital analyst Luca Issi reiterates Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Outperform and maintains $54 price target.

Reiteration

NTLA

RBC Capital Reiterates Outperform on Intellia Therapeutics, Maintains $54 Price Target

Micron Technology's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MU#NYSE">MU</a>) short percent of float has risen 54.76% since its last report. The company recently reported that it has 35.98 million shares sold short, which is 3.25% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Micron Technology Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726752614_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Micron Technology has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Micron Technology's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Micron Technology's peer group average for short interest as a percentage of float is 4.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(MU) - Analyzing Micron Technology's Short Interest

NBTX

Nanobiotix shares are trading higher after the company reported a year-over-year increase in H1 financial results.

New generative AI empowers advertisers to elevate creativity, crafting ads that captivate audiences.
Today at Accelerate, Amazon Ads announced a new feature that uses generative AI technology to make it easier for advertisers to create more interesting and relevant video ads for customers. The new feature, Video generator, creates visually rich video content in a matter of minutes and at no additional cost. Using a single product image, Video generator curates custom AI-generated videos tailored to a product's distinct selling proposition and features, leveraging Amazon's unique insights to vividly bring a product story to life.
 <a href="https://www.aboutamazon.com/news/innovation-at-amazon/amazon-ads-generative-ai-video-generator-advertisers" title="https://www.aboutamazon.com/news/innovation-at-amazon/amazon-ads-generative-ai-video-generator-advertisers">https://www.aboutamazon.com/news/innovation-at-amazon/amazon-ads-generative-ai-video-generator-advertisers</a>

AMZN

'Amazon Ads launches a new AI Video generator—here's your first look at the beta' - Blog Post

<a href="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/4147ea18-c5e3-4426-8c1f-a74f1c521777/Culper_KSPI_9-19-24.pdf?ver=1726752239297" title="https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/4147ea18-c5e3-4426-8c1f-a74f1c521777/Culper_KSPI_9-19-24.pdf?ver=1726752239297">https://img1.wsimg.com/blobby/go/cc91fda7-4669-4d1b-81ce-a0b8d77f25ab/downloads/4147ea18-c5e3-4426-8c1f-a74f1c521777/Culper_KSPI_9-19-24.pdf?ver=1726752239297</a>

KSPI

Watching Joint Stock Company Kaspi.kz; Culper Research Issues Report On Co Titled "Kaspi.kz (KSPI): The NASDAQ-Listed Fintech Moving Money for Criminals and Kleptocrats"

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0554

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0679

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0785

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0709

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0756

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0733

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0744

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0745

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0751

iShares iBonds Dec 2027 Term Treasury ETF declares monthly distribution of $0.0764

IBTH

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

iShares iBonds Dec 2027 Term Treasury ETF

Overview

iShares iBonds Dec 2027 Term Treasury ETF (NASDAQ:IBTH), Quote.Headers.trade-ideas